respiratori
tract
infect
particularli
pneumonia
lead
caus
death
person
year
older
develop
develop
countri
mani
attribut
immun
wane
advanc
age
elderli
may
suscept
respiratori
infect
even
appear
good
health
declin
abil
lymphoid
tissu
mount
antigenspecif
respons
adapt
immun
specif
microorgan
influenza
viru
streptococcu
pneumonia
thought
import
factor
increas
suscept
respiratori
tract
infect
advanc
age
howev
abnorm
innat
immun
may
also
contribut
increas
suscept
respiratori
infect
poorli
character
elderli
although
chang
immun
paramet
cell
subset
immunoglobulin
concentr
observ
respiratori
secret
older
healthi
individu
compar
younger
subject
signific
chang
protect
immun
lung
unknown
incid
pneumonia
may
lessen
measur
optim
treatment
comorbid
condit
optim
nutrit
address
swallow
disord
use
vaccin
direct
influenza
viru
pneumonia
appear
made
impact
degre
morbid
mortal
perhap
incid
communityacquir
pneumonia
howev
better
stimul
specif
immun
respons
improv
vaccin
widespread
use
vaccin
protect
elderli
individu
need
individu
advanc
age
increasingli
suscept
airway
hyperreact
dow
et
al
chronic
obstruct
pulmonari
diseas
hardi
connolli
lung
neoplasm
hendrick
hendrick
idiopath
pulmonari
fibrosi
coulta
et
al
pneumonia
marston
et
al
elderli
individu
may
prone
respiratori
problem
due
progress
impair
immun
surveil
depress
abil
mount
appropri
immun
respons
inappropri
dysregul
immun
respons
respiratori
tract
infect
particularli
pneumonia
rank
high
caus
death
elderli
mortal
rate
communityacquir
pneumonia
consider
increas
elderli
marston
et
al
although
presenc
lung
diseas
medic
condit
increas
risk
pneumonia
elderli
popul
immunosenesc
may
also
play
import
role
increas
risk
respiratori
tract
infect
addit
ageassoci
declin
lung
function
chan
welsh
may
diminish
pulmonari
reserv
increas
impact
sever
pneumonia
age
individu
although
wane
abil
immun
system
elderli
like
link
increas
risk
respiratori
tract
infect
rel
littl
known
compartment
innat
antigenspecif
adapt
immun
respons
chang
age
human
lung
much
role
ageassoci
chang
immun
respons
play
increas
suscept
respiratori
tract
infect
mani
assumpt
concern
chang
lung
immun
associ
advanc
age
made
basi
anim
studi
studi
peripher
blood
littl
research
immun
respons
within
age
human
lung
publish
date
distinct
antigenspecif
receptor
develop
lymphocyt
intrauterin
develop
give
rise
specif
adapt
immun
delv
roitt
b
adapt
immun
mediat
b
lymphocyt
deriv
pluripot
stem
cell
fetal
liver
bone
marrow
character
gener
antigenspecif
immunoglobulin
b
cell
antigenspecif
surfac
receptor
cell
estim
specif
immunoglobulin
cell
receptor
gener
via
somat
gene
rearrang
medzhitov
janeway
rel
small
number
memori
cell
retain
uniqu
antigen
although
cell
must
passag
thymu
complet
develop
adapt
respons
gener
secondari
lymphoid
tissu
includ
spleen
lymph
node
mucosaassoci
lymphoid
tissu
mucosaassoci
lymphoid
aggreg
present
throughout
lung
defend
mucos
interfac
extern
environ
innat
immun
system
tabl
reli
immunolog
memori
constantli
activ
character
immedi
respons
involv
pathogenspecif
patternrecognit
receptor
eg
mannanbind
lectin
bind
carbohydr
moieti
gramposit
gramneg
bacteria
fungi
parasit
virus
signal
receptor
eg
tolllik
receptor
induc
express
cytokin
costimulatori
molecul
phagocyt
altern
complement
pathway
antimicrobi
peptid
medzhitov
janeway
highli
conserv
pathogenassoci
molecular
structur
bound
innat
immun
system
receptor
complement
share
entir
class
microb
found
host
tissu
structur
includ
lipopolysaccharid
peptidoglycan
lipoteicho
acid
glucan
bacteri
dna
doublestrand
rna
addit
mannan
contrast
extrem
larg
number
receptor
express
lymphocyt
mediat
adapt
immun
pattern
recognit
receptor
innat
immun
system
thought
number
hundr
medzhitov
janeway
innat
immun
particularli
product
antimicrobi
peptid
huttner
bevin
antimicrobi
molecul
epitheli
cell
play
critic
import
role
protect
infect
lung
extens
epitheli
surfac
addit
innat
immun
mechan
produc
signal
trigger
adapt
immun
act
adjuv
fashion
augmentacquir
immun
respons
via
express
costimulatori
molecul
howev
rel
littl
investig
publish
concern
effect
advanc
age
innat
immun
mechan
protect
pulmonari
infect
impact
advanc
age
immun
predominantli
studi
adapt
immun
respons
consensu
immun
system
display
primari
alter
occur
healthi
well
diseas
individu
advanc
age
kirkwood
ritter
et
al
howev
secondari
chang
caus
underli
diseas
environment
factor
also
occur
consider
interindividu
variabl
primari
secondari
chang
mani
aspect
immun
remain
rel
robust
centenarian
franceschi
et
al
nonetheless
numer
alter
immun
function
observ
appar
healthi
age
individu
tabl
thymu
gradual
involut
begin
shortli
birth
almost
complet
replac
fat
age
mammalian
speci
hirokawa
et
al
therefor
lymphocyt
repertoir
compris
acquir
antigenspecif
portion
immun
creat
earli
life
gener
immunoreact
cell
respons
given
stimulu
age
individu
may
limit
tabl
alter
immun
elderli
individu
cellmedi
immun
involut
thymu
naiv
cell
output
alter
thymocyt
differenti
peripher
blood
memori
cell
hyporespons
memori
cell
prolif
respons
mitogen
antigen
cell
receptor
repertoir
divers
shift
cytokin
profil
hladr
decreas
fasmedi
apoptosi
humor
immun
helper
cell
function
b
cell
number
germin
center
format
alter
b
cell
repertoir
express
antibodi
respons
specif
antigen
alter
gener
primari
b
cell
impair
gener
memori
b
cell
abil
gener
highaffin
protect
antibodi
igg
iga
organspecif
autoantibodi
nonorganspecif
autoantibodi
innat
immun
nk
activ
impend
morbid
age
naiv
lymphocyt
popul
declin
memori
cell
tend
hyporespons
age
individu
predomin
jackola
et
al
brosch
platt
linton
et
al
moreov
number
retain
memori
cell
given
antigen
specif
small
host
depend
upon
rapid
clonal
expans
respons
antigen
exposur
mount
effect
immun
respons
invad
microorgan
contain
innat
immun
respons
mechan
alon
investig
lymphocyt
dysfunct
advanc
age
shown
declin
cell
surfac
costimulatori
molecul
express
function
alter
intracellular
signal
pathway
engwerda
et
al
rea
et
al
garcia
miller
antigen
present
dendrit
cell
cytokin
product
profil
alter
less
effici
pahlavani
richardson
addit
divers
b
cell
receptor
repertoir
appear
declin
nicoletti
et
al
liu
et
al
helper
activ
diminish
li
et
al
memori
cell
less
respons
stimuli
flurkey
et
al
addit
alter
includ
declin
fasmedi
apoptosi
zhou
et
al
reduct
prolif
respons
antigen
mitogen
lerner
et
al
linton
et
al
miller
et
al
increas
express
dr
cell
jackola
et
al
shift
type
helper
cell
type
cytokin
profil
cakman
et
al
tabl
antibodi
product
respons
specif
antigen
depress
antibodi
tend
diminish
affin
specif
antigen
song
et
al
therefor
surpris
elderli
individu
display
agerel
declin
protect
immun
variou
natur
infect
well
less
vigor
respons
vaccin
consequ
immunosenesc
infecti
diseas
particularli
pneumonia
bronchiti
influenza
gastroenter
major
caus
debilit
death
elderli
nonetheless
despit
evid
declin
immun
function
advanc
age
unselect
popul
elderli
individu
mani
centenarian
fairli
good
immun
function
includ
rel
persist
naiv
cell
wellfunct
nk
cell
franceschi
et
al
solana
mariani
mani
interest
observ
compar
healthi
ill
centenarian
individu
report
suggest
immun
chang
associ
impend
ill
decreas
longev
other
found
healthi
individu
although
peripher
blood
lymphocyt
number
appear
correl
age
healthi
elderli
peopl
peripher
lymphocyt
count
declin
individu
year
prior
death
compar
valu
obtain
year
earlier
bender
et
al
anoth
longitudin
studi
found
cluster
four
paramet
poor
cell
prolif
respons
high
lymphocyt
low
lymphocyt
low
b
cell
predict
shorten
surviv
although
singl
paramet
predict
ferguson
et
al
final
individu
appear
age
rapidli
peer
demonstr
physiolog
impair
shown
dysregul
proinflammatori
cytokin
tumor
necrosi
factor
verderi
lung
uniqu
qualiti
share
skin
gastrointestin
tract
organ
also
constantli
expos
extern
environ
one
qualiti
lung
possess
larg
number
dendrit
cell
antigenpresent
well
larg
number
mucos
lymphocyt
drain
lymph
node
would
greatli
facilit
adapt
immun
respons
howev
innat
immun
system
key
compon
respiratori
tract
defens
provid
constant
immedi
protect
microbi
invas
epithelia
conduct
airway
lung
like
upper
airway
skin
gastrointestin
genitourinari
tract
produc
divers
antibacteri
peptid
defensin
tracheal
antimicrobi
peptid
huttner
bevin
peptid
microbicid
probabl
import
confer
continu
protect
host
complement
protect
provid
protein
secretori
iga
conduct
airway
surfactantassoci
protein
produc
type
ii
alveolar
epitheli
cell
antigenspecif
immun
respons
apt
trigger
innat
defens
overwhelm
unfortun
littl
known
innat
immun
age
human
lung
whether
chang
occur
increas
suscept
respiratori
infect
howev
chang
immun
paramet
respiratori
secret
reflect
bronchoalveolar
lavag
report
tabl
increas
number
memori
cell
express
increas
amount
hladr
appear
accumul
mucos
surfac
healthi
elderli
individu
meyer
et
al
meyer
soergel
increas
concentr
immunoglobulin
also
observ
bronchoalveolar
lavag
fluid
thompson
et
al
meyer
et
al
increas
immunoglobulin
concentr
may
reflect
tendenc
older
healthi
individu
display
shift
toward
cytokin
profil
lung
increas
cytokin
express
possibl
accompani
decreas
cytokin
eg
interferong
express
although
frequent
present
bronchoalveolar
lavag
old
normal
individu
meyer
et
al
vs
cytokin
profil
investig
respiratori
secret
lung
tissu
old
vs
young
clinic
normal
individu
interestingli
increas
number
neutrophil
also
observ
bronchoalveolar
lavag
fluid
clinic
normal
elderli
individu
meyer
suggest
degre
lowgrad
mucos
inflamm
may
present
age
human
lung
healthi
individu
chang
may
reflect
heighten
host
respons
consequ
continu
exposur
inhal
environment
agent
perhap
augment
longer
retent
lung
due
diminish
mucociliari
clearanc
advanc
age
loss
regulatori
suppress
inflammatori
respons
andor
adapt
respons
subclin
aspir
due
depress
protect
reflex
associ
advanc
age
individu
studi
healthi
normal
lung
function
increas
number
memori
cell
immunoglobulin
may
repres
select
bia
character
adapt
protect
chang
healthi
individu
respiratori
infect
usual
caus
bacteria
lead
caus
morbid
mortal
communityacquir
pneumonia
nurs
home
resid
elderli
popul
marri
feldman
torr
et
al
howev
variou
secondari
chang
comorbid
appear
play
major
role
predispos
elderli
individu
bacteri
pneumonia
addit
ageassoci
alter
immun
statu
secondari
chang
comorbid
includ
malnutrit
presenc
lung
heart
diseas
predisposit
aspir
due
swallow
disord
depress
level
alert
alcohol
immunosuppress
therapi
institution
recent
hospit
enhanc
oropharyng
bacteri
colon
prior
antibiot
therapi
ageassoci
declin
mucociliari
clearanc
incalzi
et
al
rel
blunt
glottic
protect
reflex
aviv
concert
declin
protect
immun
capac
may
particularli
import
elderli
individu
appear
healthi
lack
comorbid
nonetheless
develop
communityacquir
bacteri
pneumonia
spectrum
caus
pathogen
vari
set
pneumonia
occur
pneumonia
sever
comorbid
situat
need
consid
make
treatment
decis
common
pathogen
identifi
caus
pneumonia
adult
remain
streptococcu
pneumonia
gramneg
bacilli
hemophilu
influenza
legionella
staphylococcu
aureu
frequent
identifi
pathogen
communityacquir
pneumonia
decis
guidelin
regard
hospit
treatment
vari
accord
age
sever
infect
presenc
comorbid
condit
particular
concern
evolut
antibiot
resist
pneumonia
bacteri
pathogen
pneumococc
isol
identifi
resist
penicillin
azithromycin
newer
fluoroquinolon
levofloxacin
newer
antibiot
class
ketolid
activ
drugresist
pneumonia
may
also
gradual
lose
efficaci
widespread
usag
viral
ill
may
also
play
import
role
predispos
elderli
individu
subsequ
seriou
lower
respiratori
tract
bacteri
infect
observ
influenza
treanor
falsey
addit
influenza
b
respiratori
syncyti
viru
caus
seriou
infect
elderli
immunocompromis
patient
frail
elderli
cardiopulmonari
diseas
parainfluenza
viru
also
caus
signific
infect
rhinoviru
coronaviru
caus
seriou
infect
frail
elderli
addit
viral
infect
tuberculosi
present
signific
worldwid
problem
age
popul
infect
seemingli
normal
individu
increasingli
encount
obrien
influenza
viru
infect
elderli
signific
morbid
mortal
increas
risk
associ
bacteri
pneumonia
greatli
diminish
function
statu
postconvalesc
period
communityacquir
pneumonia
elderli
associ
increas
sever
infect
increas
likelihood
hospit
pulmonari
complic
increas
mortal
immun
influenza
b
pneumonia
remain
common
bacteri
pathogen
identifi
caus
communityacquir
pneumonia
play
import
role
pneumonia
prevent
inde
current
use
polysaccharid
vaccin
pneumonia
appear
protect
bacteremia
decreas
incid
communityacquir
pneumonia
due
pneumonia
atrisk
popul
sim
et
al
similarli
current
use
influenza
vaccin
shown
protect
corrigan
clanci
howev
vaccin
rate
elderli
caucasian
influenza
pneumonia
vaccin
rate
consider
lower
african
american
hispan
novel
vaccin
use
mucos
surfac
achiev
immun
may
improv
vaccin
efficaci
live
attenu
influenza
viru
use
infect
replic
respiratori
tract
eg
intranas
applic
therebi
deliv
larger
dose
immunogen
bronchusassoci
lymphoid
tissu
natur
infect
induc
crossprotect
iga
antibodi
hemagglutinin
protect
influenza
variant
corrigan
clanci
hand
oral
administr
inactiv
viru
depend
upon
peyer
patch
mount
respons
may
provid
effect
immun
pang
et
al
combin
parenter
inactiv
viru
intranas
live
attenu
viru
may
prove
efficaci
although
current
use
pneumococc
polysaccharid
vaccin
confer
protect
pneumonia
respiratori
infect
newer
approach
use
conjug
vaccin
elicit
higher
level
antibodi
via
celldepend
mechan
induct
larger
number
memori
b
cell
may
increas
protect
butler
et
al
addit
vaccin
direct
noncapsular
antigen
common
pneumococc
serotyp
pneumolysin
surfac
adhesin
surfac
protein
would
provid
protect
pneumococc
serotyp
dna
technolog
wherein
dna
plasmid
carri
proteinencod
gene
incorpor
host
cell
may
prove
particularli
effect
butler
et
al
although
vaccin
play
import
role
prevent
respiratori
infect
elderli
factor
optim
nutrit
antioxid
calor
restrict
play
immunomodulatori
role
may
improv
immun
respons
resist
pulmonari
infect
elderli
tabl
proteinenergi
malnutrit
occur
appar
healthi
elderli
individu
advers
alter
lymphocyt
subset
cytokin
releas
even
impair
monocyt
polymorphonuclear
leukocyt
function
lesourd
addit
micronutri
defici
eg
zinc
selenium
vitamin
e
folat
shown
diminish
variou
immun
indic
lesourd
furthermor
dietari
supplement
vitamin
e
andor
c
shown
antagon
even
restor
ageassoci
declin
immun
function
de
la
therapi
use
neuraminidas
inhibitor
given
earli
cours
ill
influenza
viru
infect
may
attenu
morbid
mortal
well
prevent
subsequ
bacteri
pneumonia
similarli
administr
immunomodulatori
agent
interferong
may
improv
outcom
mycobacteri
infect
particularli
caus
drugresist
atyp
organ
declin
immun
respons
observ
system
may
help
explain
part
increas
suscept
pulmonari
infect
advanc
age
howev
secondari
factor
particularli
cigarett
smoke
structur
lung
damag
also
play
import
role
respiratori
infect
elderli
individu
although
combin
primari
immunosenesc
secondari
factor
probabl
involv
increas
suscept
pneumonia
elderli
littl
investig
done
compartment
immun
respons
age
lung
research
focus
integr
mucos
immun
age
lung
may
identifi
chang
increas
suscept
respiratori
tract
infect
evid
seem
accumul
dietari
factor
includ
calor
restrict
avoid
proteinenergi
malnutrit
micronutri
supplement
antioxid
usag
may
improv
immun
function
age
individu
avoid
high
fat
diet
treatment
hyperlipidemia
may
also
play
role
maintain
optim
immun
function
elderli
clearli
use
effect
vaccin
strategi
need
like
major
impact
morbid
mortal
respiratori
tract
infect
elderli
fuent
et
al
enioutina
et
al
moriguchi
moruga
like
basi
antioxid
properti
vitamin
e
shown
significantli
reduc
influenza
viru
titer
age
mice
han
meydani
calor
restrict
signific
modul
age
process
laboratori
anim
also
appear
attenu
ageassoci
immunosenesc
pahlavani
richardson
interestingli
alter
lipid
metabol
suggest
import
factor
optim
immun
reactiv
elderli
wick
grubeckloebenstein
high
cholesterol
phospholipid
ratio
lymphocyt
cell
membran
impair
cell
respons
lowdens
lipoprotein
ldl
receptor
cell
age
individu
decreas
sensit
plasma
ldl
lead
increas
cholesterol
phospholipid
ratio
cell
membran
lymphocyt
age
individu
author
specul
diet
lipidlow
drug
may
improv
cell
respons
elderli
maintain
improv
membran
fluiditi
measur
taken
prevent
pneumonia
includ
optim
social
situat
medic
treatment
elderli
treat
comorbid
condit
avoid
medic
like
depress
alert
decreas
aspir
risk
deal
adequ
malnutrit
import
intervent
often
success
implement
addit
effect
rel
safe
